Paclitaxel, interferons and functional reprogramming of tumor-associated macrophages in optimized chemo-immunotherapy is a research paper published in Journal for ImmunoTherapy of Cancer (2025). On theSindex it has a DataRank of 0.396. It has been cited 13 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.396
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →DOD Peer Reviewed Cancer Research Program
Grant: W81XWH-19-1-0674
National Cancer Institute
Grant: K08CA279766
National Cancer Institute
Grant: P01CA234212
National Cancer Institute
Grant: P50CA159981
National Center for Advancing Translational Sciences
Grant: KL2TR001413
National Center for Advancing Translational Sciences
Grant: R03TR004607
National Center for Advancing Translational Sciences
Grant: UL1TR001412
National Institutes of Health
Grant: 5KL2TR001413-03
Buffalo Clinical and Translational Research Center
National Institutes of Health
Grant: 3UL1TR001412-08S3
Buffalo Clinical and Translational Research Center
National Institutes of Health
Grant: 1R03TR004607-01
Identifying the role of interferon and interferon-regulated chemokines in stress-induced immunosuppression in triple negative breast cancer
National Institutes of Health
Grant: 7K08CA279766-02
Stress-induced immunosuppression via downregulation of interferon in triple negative breast cancer
National Institutes of Health
Grant: 5P01CA234212-02
Targeting the Chemokine System to Sensitize Tumors to Immunotherapy
National Institutes of Health
Grant: 1P50CA159981-01A1
MHC-Restricted and MHC-Non-Restricted Targeting of Ovarian Cancer by alphaDC1
Roswell Alliance Foundation
Jacobs Family Foundation
FWCI
4.91
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals